Kerr Holbrook Sells 15,000 Shares of Avanos Medical (NYSE:AVNS) Stock

Avanos Medical, Inc. (NYSE:AVNS) SVP Kerr Holbrook sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $11.00, for a total value of $165,000.00. Following the sale, the senior vice president owned 83,860 shares in the company, valued at approximately $922,460. The trade was a 15.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Avanos Medical Price Performance

AVNS stock traded down $0.03 during mid-day trading on Wednesday, reaching $11.22. 336,724 shares of the company traded hands, compared to its average volume of 542,336. The company has a fifty day moving average price of $11.56 and a 200-day moving average price of $11.85. Avanos Medical, Inc. has a 52-week low of $9.30 and a 52-week high of $19.91. The company has a market capitalization of $520.60 million, a P/E ratio of -1.10 and a beta of 1.19. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.38 and a quick ratio of 1.36.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.10. The company had revenue of $177.80 million during the quarter, compared to analyst estimates of $164.50 million. Avanos Medical had a negative net margin of 67.00% and a positive return on equity of 6.21%. Avanos Medical’s revenue was up 4.3% compared to the same quarter last year. During the same period last year, the business earned $0.33 earnings per share. Avanos Medical has set its FY 2025 guidance at 0.850-0.950 EPS. As a group, analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Versant Capital Management Inc increased its holdings in Avanos Medical by 49.7% during the third quarter. Versant Capital Management Inc now owns 2,692 shares of the company’s stock valued at $31,000 after buying an additional 894 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in Avanos Medical by 969.3% during the second quarter. Russell Investments Group Ltd. now owns 2,545 shares of the company’s stock worth $31,000 after buying an additional 2,307 shares during the period. Wexford Capital LP bought a new stake in Avanos Medical in the third quarter worth about $70,000. Tower Research Capital LLC TRC grew its position in Avanos Medical by 433.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,257 shares of the company’s stock valued at $77,000 after acquiring an additional 5,083 shares during the last quarter. Finally, Quantessence Capital LLC purchased a new position in shares of Avanos Medical during the third quarter worth approximately $116,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AVNS. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a research report on Tuesday, October 14th. Zacks Research upgraded Avanos Medical to a “hold” rating in a research report on Tuesday, August 12th. Finally, Wall Street Zen upgraded shares of Avanos Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Avanos Medical currently has an average rating of “Reduce”.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.